This is a community-generated profile. If you would like to claim it, please .
Precigen
Develops gene & cell therapies for immuno-oncology, autoimmune disorders & infectious diseases51-200 EmployeesActively Hiring
Precigen Funding
$100M
11 round
Precigen is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $100M. Their most recent funding was raised on September 2, 2025.
Funding Rounds
S
$100000000